The National Institute for Health and Care Excellence (NICE) on 31st January 2022 published its new ...
Read moreAs we enter 2022, we are approaching the two-year anniversary of the COVID-19 pandemic spreading acr...
Read moreReviewing previous HTA submissions can provide valuable insights that can help manufacturers prepare...
Read moreIs the National Institute for Health and Care Excellence (NICE) becoming more efficient in evaluatin...
Read moreThe purpose of this study is to compare the assessments of orphan and non-orphan drugs by NICE.
Read moreWhen making a decision about the approval of a new product NICE (National Institute for Health and C...
Read moreThe Head of Agency Group (HAG) is a recently launched network created by the European Health Technol...
Read moreClinical evidence relating to therapeutic efficacy and safety is one of the most valuable criteria o...
Read moreThe European Parliament and Council negotiators reached a provisional agreement on a joint health te...
Read moreAre we one step closer to an EU Health Technology Assessment body. The EESC publish its positive opi...
Read more